HAVLF
Healthcare BiotechnologyHAVN Life Sciences Inc.
$0.00
-0.00 -0.00% today
Price History
Not enough data
Key Stats
Market Cap
1,473.861
Avg Volume
0
EPS
-$0.44
52W High
$0.01
52W Low
$0.00
Div. Yield
0.0%
Valuation
P/B Ratio
0.00
P/S Ratio
0.00
EV/EBITDA
-0.00
EV/Revenue
0.02
Margins
Gross Margin 35.5%
Operating Margin 5362.7%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Return on Equity
(234.5%)
Return on Assets
(30.3%)
Liquidity & Leverage
Current Ratio
2.68
Quick Ratio
0.60
Debt / Equity
0.03
Total Cash
13,986
Total Debt
26,234
About
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is based in Port Moody, Canada.
www.havnlife.com